Drug Development Needs “Clean-Slate Think” To Involve Patients All Along The Way

“…Pfizer executive Freda Lewis-Hall is calling on the drug industry to develop a framework to ensure patient participation throughout the drug development process…Lewis-Hall’s comments align with the philosophy underlying FDA’s patient-focused drug development initiative, mandated under PDUFA V, although there the emphasis is specifically on diseases with few or no current treatments and for which aspects of the disease are not formally captured in clinical trials.” Paid Subscription Required. (Source: The Pink Sheet, 5/21/2013)